rebuild solid foundat pipelin option
analyst certif import disclosur see
rebuild solid foundat pipelin option
announc restructur plan includ new guidanc follow discontinu go forward focu
effort view solid foundat partner pd wholli own attr amyloidosi
encourag initi studi current enrol target enrol patient preliminari data
base proprietari mis-ttr assay anticip also develop preclin pipelin includ a-target antibodi
three partner compound celg view advanc clinic confirm compani discoveri
platform valid extern partnership
difficult fl enter year better momentum comps/margin beat expect flow premium product
continu improv innov scale north america athlet landscap final becom ration europ remain
difficult bigger penetr still reset peak inventori overhang come fl us comp posit
first time sinc basketbal categori start stabil lsd vs hsd still strength run model
flattish comp think may improv vs monthli compar eas lsd share strongli
today valuat still inexpens rais
top stori week cbo issu latest project includ uninsur next decad compar prior
expect howev impact attribut individu mandat repeal reduc previous
deliv second consecut quarter strong top-lin perform underli sale growth ahead guidanc
out-performance led stronger ou particular emerg market ep also outperform aid higher sale
lower interest expense/tax rate guid sale growth ep includ tailwind fx underli
oper margin expans target led new cost-sav initi believ repatri cash provid dri powder compani
liquid ou asset next quarter biennial investor analyst day june expect comprehens
pipelin updat well detail cost-saving/cash-flow initi
